Know Cancer

or
forgot password

Pilot Study to Investigate the Role of Metabolic Imaging in Predicting Tumor Response and Outcome After Therapy for Pancreatic Cancer


N/A
18 Years
N/A
Not Enrolling
Both
Pancreatic Cancer

Thank you

Trial Information

Pilot Study to Investigate the Role of Metabolic Imaging in Predicting Tumor Response and Outcome After Therapy for Pancreatic Cancer


Inclusion Criteria:

- Adult patients (>18) with histologically confirmed adenocarcinomas of
the pancreas with a - treatment plan consisting of definitive or palliative radiation
therapy and/or chemotherapy with or without surgery.

- Negative urine pregnancy test if a woman of child-bearing potential (WOCBP).

- WOCBP must be using an adequate method of contraception to avoid pregnancy throughout
the study period.

- All patients will be evaluated in a uniform manner at the Stanford GI Combined
Modality Tumor Board to determine eligibility.

Exclusion Criteria:1. Uncontrolled intercurrent illness including, but not limited to,
ongoing or active infection, symptomatic congestive heart failure, unstable angina
pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit
compliance with study requirements.

2. Any concurrent malignancy other than non-melanomaskin cancer, or carcinomainsitu of the
cervix. Patients with a previous malignancy without evidence of disease for >5 years will
be allowed to enter the trial.

3. WOCBP who is pregnant or breastfeeding. 4. Inability to sign written consent.

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Evaluate the performance of the novel imaging methods

Outcome Time Frame:

unknown

Safety Issue:

No

Principal Investigator

Albert Koong

Investigator Role:

Principal Investigator

Investigator Affiliation:

Stanford University

Authority:

United States: Institutional Review Board

Study ID:

PANC0004

NCT ID:

NCT00767273

Start Date:

October 2006

Completion Date:

December 2007

Related Keywords:

  • Pancreatic Cancer
  • Pancreatic Neoplasms

Name

Location

Stanford University School of MedicineStanford, California  94305-5317